Results 11 to 20 of about 11,997 (297)

l-3,4-Dihydroxyphenylalanine induces ptosis through a GPR143-independent mechanism in mice [PDF]

open access: yesJournal of Pharmacological Sciences, 2016
Through its conversion to dopamine by aromatic l-amino acid decarboxylase (AADC), l-3,4-dihydroxyphenylalanine (l-DOPA) replenishes depleted brain dopamine in Parkinson's disease patients. We recently identified GPR143 as a candidate receptor for l-DOPA.
Suguru Ueda   +3 more
doaj   +2 more sources

Role of l-3,4-Dihydroxyphenylalanine in Mussel Adhesive Proteins [PDF]

open access: yes, 2016
Role of l-3,4-Dihydroxyphenylalanine in Mussel Adhesive ...
Jungyeon Hwang (1413049)   +2 more
core   +1 more source

Effects of Aging on Levo-Dihydroxyphenylalanine- Induced Dyskinesia in a Rat Model of Parkinson’s Disease

open access: yesFrontiers in Aging Neuroscience, 2021
BackgroundIt remains unclear why patients with young-onset Parkinson’s disease more often develop levo-dihydroxyphenylalanine (L-dopa)-induced dyskinesia (LID) and have a more severe form than patients with old-onset Parkinson’s disease. Previous studies
Haruo Nishijima   +8 more
doaj   +1 more source

Oxidation of peptidyl 3,4-Dihydroxyphenylalanine analogues: Implications for the biosynthesis of tunichromes and related oligopeptides [PDF]

open access: yes, 1991
The o-diphenolic amino acid l-3,4-dihydroxyphenylalanine (dopa), the enamine α, β-dehydro-3,4-dihydroxyphenylalanine (Δ-dopa), and/or hydroxylated derivatives thereof, are integrated into the primary sequence of many scleroproteins and polyphenolic ...
Taylor S.W.   +3 more
core   +1 more source

One-pot synthesis of 6-l-[18f] fluoro-3,4-dihydroxyphenylalanine (6-l-[18f] fdopa). [PDF]

open access: yes
The invention relates to the field of medicinal chemistry and radiopharmaceuticals, in particular to means, methods and cassettes for the automated synthesis of the radiotracer 6-L-[18F]fluoro-3,4- dihydroxyphenylalanine (6-L-[18F]FDOPA).
Elsinga, Philippus Hein   +5 more
core   +10 more sources

Genetic associations of single nucleotide polymorphisms in the l-DOPA receptor (GPR143) gene with severity of nicotine dependence in Japanese individuals, and attenuation of nicotine reinforcement in Gpr143 gene-deficient mice

open access: yesJournal of Pharmacological Sciences, 2020
l-3,4-dihydroxyphenylalanine (l-DOPA) is a candidate neurotransmitter. l-DOPA is released by nicotine through nicotinic receptors. Recently, G-protein coupled receptor GPR143, was identified as a receptor for l-DOPA.
Daiki Masukawa   +13 more
doaj   +1 more source

Early diagnosis of focal congenital hyperinsulinism: A fluorine-18-labeled l-dihydroxyphenylalanine positron emission tomography/computed tomography study

open access: yesWorld Journal of Nuclear Medicine, 2021
Congenital hyperinsulinism (CHI) is responsible for hyperinsulinemic hypoglycemia which needs aggressive treatment in order to prevent neurological damages.
Luca Burroni   +3 more
doaj   +1 more source

3,4-Dihydroxyphenylalanine gel diffusion assay for polyphenol oxidase quantification [PDF]

open access: yes, 2008
We have developed a simple, inexpensive plate assay to detect and quantify polyphenol oxidase (PPO) activity from different origins. The logarithm of enzyme activity is linearly correlated with the diameter of the dark, L-3,4-dihydroxyphenylalanine (L ...
LANTE, ANNA, LOMOLINO, GIOVANNA, ZOCCA F
core   +1 more source

Genetic incorporation ofl-dihydroxyphenylalanine (DOPA) biosynthesized by a tyrosine phenol-lyase [PDF]

open access: yes, 2018
l-Dihydroxyphenylalanine (DOPA) was biosynthesized by a tyrosine-phenol lyase from catechol, pyruvate, and ammonia inEscherichia coli, and the biosynthesized amino acid was directly incorporated into proteins.
Hyun Soo Lee   +6 more
core   +1 more source

Effect of Selective Serotonin Reuptake Inhibitors via 5-HT1A Receptors on L-DOPA-Induced Rotational Behavior in a Hemiparkinsonian Rat Model

open access: yesJournal of Pharmacological Sciences, 2012
l-Dihydroxyphenylalanine (l-DOPA) is considered the gold standard for the treatment of Parkinson’s disease (PD). However, long-term administration of l-DOPA can induce abnormal side effects.
Masatoshi Inden   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy